E2F transcription factor 2 variants as predictive biomarkers for recurrence risk in patients with squamous cell carcinoma of the oropharynx.
- AnnotationCompared with patients with variant genotypes of E2F2-rs2742976 and E2F2-rs3218123 patients with common homozygous genotypes had better disease-free survival (both log-rank P < 0.001) and lower squamous cell carcinoma of the oropharynx recurrence risk (HR 0.4 95% CI 0.3-0.6 and HR 0.3 95% CI 0.2-0.5 respectively) after multivariable adjustment.
- CategoriesSequences
- SourceGeneRif: 1870